WILMINGTON, Del. — DuPont has entered into a definitive agreement to acquire Spectrum Plastics Group from AEA Investors. The transaction is expected to close by the end of the third quarter of 2023, subject to regulatory approvals and other customary closing conditions.

Spectrum is a recognized leader in advanced manufacturing of specialty medical devices and components, serving 22 of the top 26 medical device OEMs with a strategic focus on key, fast-growing therapeutic areas such as structural heart, electrophysiology, surgical robotics and cardiovascular.

“We have been focused on Spectrum for a long time and our team is extremely excited for this opportunity,” said Ed Breen, executive chairman and CEO of DuPont. “Spectrum is a compelling strategic complement to our existing healthcare portfolio, which already includes businesses with best-in-class innovation, deep customer relationships and with strong growth and profitability. With this combination, we’ll be able to offer customers additional innovation and manufacturing capabilities with a broader and more integrated solution set.”